Abstract
ABSTRACT The use of tizanidine is well established in spasticity due to multiple sclerosis (MS), spinal cord injury, and cerebrovascular disease. Refinement of the use oftizanidine in these areas is ongoing. To date, most large studies have focused primarily on measurement of changes in abnormalities of tone and spasm frequency rather than changes related to improved function. More detailed studies may help to better elucidate the impact of tizanidine and other spasticity treatments on activities of daily living and overall quality of life of MS patients. (Int J MS Care. 2001; 3(1): 29–31)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
